Literature DB >> 12462208

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Norman K Hollenberg1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12462208     DOI: 10.1007/s11906-002-0018-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  2 in total

1.  Inducible nitric oxide synthase attenuates endothelium-dependent renal microvascular vasodilation.

Authors:  Atsuhiro Ichihara; Matsuhiko Hayashi; L Gabriel Navar; Takao Saruta
Journal:  J Am Soc Nephrol       Date:  2000-10       Impact factor: 10.121

2.  Genetic analysis of nitric oxide and endothelin in end-stage renal disease.

Authors:  B I Freedman; H Yu; P J Anderson; B H Roh; S S Rich; D W Bowden
Journal:  Nephrol Dial Transplant       Date:  2000-11       Impact factor: 5.992

  2 in total
  2 in total

Review 1.  Management of Heart Failure in Patients with Chronic Kidney Disease.

Authors:  David K Ryan; Debasish Banerjee; Fadi Jouhra
Journal:  Eur Cardiol       Date:  2022-07-26

2.  Do Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis Have the Same Clinical Outcomes? A Ten-year Cohort Study in Taiwan.

Authors:  Chao-Hsiun Tang; Tso-Hsiao Chen; Te-Chao Fang; Siao-Yuan Huang; Kuan-Chih Huang; Yu-Ting Wu; Chia-Chen Wang; Yuh-Mou Sue
Journal:  Sci Rep       Date:  2016-07-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.